Found: 28
Select item for more details and to access through your institution.
Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01564-y
- By:
- Publication type:
- Article
First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0177-y
- By:
- Publication type:
- Article
Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.
- Published in:
- Innovations in Clinical Neuroscience, 2017, v. 14, n. 1/2, p. 22
- By:
- Publication type:
- Article
Organ Biomarker Responses in Patients With Light Chain Amyloidosis Treated With NEOD001 Are Independent of Previous Hematologic Response.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e97, doi. 10.1016/j.clml.2017.03.175
- By:
- Publication type:
- Article
NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From a Phase 1/2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e22, doi. 10.1016/j.clml.2017.03.038
- By:
- Publication type:
- Article
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.
- Published in:
- Brain Imaging & Behavior, 2014, v. 8, n. 2, p. 183, doi. 10.1007/s11682-013-9262-z
- By:
- Publication type:
- Article
A data‐driven examination of apathy and depressive symptoms in dementia with independent replication.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 1, p. 1, doi. 10.1002/dad2.12398
- By:
- Publication type:
- Article
A Phase 1 First‐in‐Human Single‐Ascending‐Dose Trial With ESB1609, a Selective Agonist to the Sphingosine‐1‐Phosphate Receptor 5.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 625, doi. 10.1002/cpdd.1256
- By:
- Publication type:
- Article
Sex Modulates the Pathological Aging Effect on Caudate Functional Connectivity in Mild Cognitive Impairment.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.804168
- By:
- Publication type:
- Article
"Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 1, p. 153, doi. 10.1016/j.jalz.2018.11.002
- By:
- Publication type:
- Article
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 4, p. 535, doi. 10.1016/j.jalz.2018.02.018
- By:
- Publication type:
- Article
2017 NIA-AA RESEARCH FRAMEWORK TO INVESTIGATE THE ALZHEIMER’S DISEASE CONTINUUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P890, doi. 10.1016/j.jalz.2017.07.294
- By:
- Publication type:
- Article
POOLED AMYLOID PET BASELINE DATA FROM THE BAPINEUZUMAB IV PHASE III TRIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P614, doi. 10.1016/j.jalz.2016.06.1219
- By:
- Publication type:
- Article
Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC-001) in mild-to-moderate and early Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P276, doi. 10.1016/j.jalz.2015.07.366
- By:
- Publication type:
- Article
The impact of reference region on the variance of estimated change in PET amyloid standard uptake value ratios measured longitudinally in summit and acction.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P547, doi. 10.1016/j.jalz.2015.06.696
- By:
- Publication type:
- Article
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 840, doi. 10.1016/j.jalz.2015.04.001
- By:
- Publication type:
- Article
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 5, p. e111, doi. 10.1016/j.jalz.2013.05.1769
- By:
- Publication type:
- Article
The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 1, p. S1, doi. 10.1016/j.jalz.2011.09.172
- By:
- Publication type:
- Article
Relationship between patient dependence on others and clinical measures of cognition, function and behavior in Alzheimer's disease (AD): Results from a longitudinal study
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Immunotherapy with bapineuzumab lowers CSF tau protein levels in patients with Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Estimating dependence scale scores based on clinical dementia rating - sum of boxes scores in patients with mild cognitive impairment or mild to moderate Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer's disease.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23755-z
- By:
- Publication type:
- Article
Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease.
- Published in:
- International Journal of Alzheimer's Disease, 2012, p. 1, doi. 10.1155/2012/628070
- By:
- Publication type:
- Article
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34129-4
- By:
- Publication type:
- Article
Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
- Published in:
- International Journal of Geriatric Psychiatry, 2023, v. 38, n. 6, p. 1, doi. 10.1002/gps.5952
- By:
- Publication type:
- Article
Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor.
- Published in:
- Movement Disorders, 2021, v. 36, n. 6, p. 1362, doi. 10.1002/mds.28490
- By:
- Publication type:
- Article
Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor.
- Published in:
- Movement Disorders, 2021, v. 36, n. 6, p. 1362, doi. 10.1002/mds.28490
- By:
- Publication type:
- Article